Abstract
Ïã¸ÛÁùºÏ²Ê¿ª½±/TS 20451:2017 defines the concepts required to associate pharmaceutical products with an appropriate set of PhPID(s) in accordance with Ïã¸ÛÁùºÏ²Ê¿ª½± 11616.
Pharmaceutical identifiers and elements are to represent pharmaceutical products as represented in a Medicinal Product as indicated by a Medicines Regulatory Authority. The suite of Ïã¸ÛÁùºÏ²Ê¿ª½± IDMP standards can be applied to off-label usage of Medicinal Products, but is currently outside of the scope of Ïã¸ÛÁùºÏ²Ê¿ª½±/TS 20451:2017.
Reference to Ïã¸ÛÁùºÏ²Ê¿ª½± 11238, Ïã¸ÛÁùºÏ²Ê¿ª½± 11239, Ïã¸ÛÁùºÏ²Ê¿ª½± 11240 and Ïã¸ÛÁùºÏ²Ê¿ª½± 11615 and HL7 messaging standards, HL7 Reference Information Model (RIM), HL7 V3 Common Product Model (CPM) and HL7 V3 Structured Product Labelling (SPL) can be applied for pharmaceutical product information in the context of Ïã¸ÛÁùºÏ²Ê¿ª½±/TS 20451:2017.
General information
-
Status: PublishedPublication date: 2017-10Stage: International Standard to be revised [90.92]
-
Edition: 1Number of pages: 48
-
Technical Committee :Ïã¸ÛÁùºÏ²Ê¿ª½±/TC 215ICS :35.240.80
- RSS updates
Life cycle
-
Now
PublishedÏã¸ÛÁùºÏ²Ê¿ª½±/TS 20451:2017
A standard is reviewed every 5 years
Stage: 90.92 (To be revised) -
Will be replaced by
Under developmentÏã¸ÛÁùºÏ²Ê¿ª½±/AWI TS 20451
Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)